Company Filing History:
Years Active: 1992-1993
Title: Innovations in Cardiac Treatment by Andreas Stark
Introduction
Andreas Stark is a notable inventor based in Radebeul, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating cardiac arrhythmia. With a total of 2 patents to his name, Stark's work is paving the way for new therapeutic options in heart health.
Latest Patents
Stark's latest patents include the innovative 3-carbalkoxyamino-5-(alpha-aminopropionyl)-5H-dibenz[b,f]azepines and their pharmaceutically acceptable salts. These compounds have been identified as suitable actives for the treatment of cardiac arrhythmia. Additionally, previously unknown 3-carbalkoxyamino-5-(alpha-halogenpropionyl)-5H-dibenz[b,f]azepines are synthesized through reactions with alpha-halogenpropionyl halides. The new compounds can be further processed with ammonia or amines to yield the desired target products, which may also be converted into their pharmaceutically acceptable acid addition salts. These advancements highlight the potential of Stark's inventions as antiarrhythmic agents in addressing heart disorders.
Career Highlights
Andreas Stark is currently associated with Arzneimittelwerk Dresden GmbH, where he continues to innovate in the pharmaceutical sector. His work focuses on the synthesis of new compounds that can significantly impact the treatment of heart conditions. Stark's dedication to research and development has positioned him as a key figure in the field.
Collaborations
Stark collaborates with esteemed colleagues such as Helmut Wunderlich and Dieter Lohmann. Their combined expertise enhances the research and development efforts at Arzneimittelwerk Dresden GmbH, fostering an environment of innovation.
Conclusion
Andreas Stark's contributions to cardiac treatment through his innovative patents demonstrate the importance of research in developing effective therapies. His work not only advances medical science but also offers hope for patients suffering from heart disorders.